Rocco Latorre Selected Research

Rocco Latorre Research Topics

Disease

11	Pain (Aches) 01/2023 - 01/2018
6	Hyperalgesia 01/2022 - 01/2018
4	Constipation 01/2022 - 01/2015
4	Colitis 01/2022 - 01/2018
3	Chronic Pain 01/2022 - 12/2019
3	Hypersensitivity (Allergy) 01/2020 - 01/2018
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2022 - 09/2021
2	Inflammation (Inflammations) 01/2022 - 12/2014
2	Visceral Pain 01/2022 - 01/2018
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2021
2	Obesity 01/2016 - 04/2010
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Migraine Disorders (Migraine) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Neoplasms (Cancer) 09/2021
1	Mouth Neoplasms (Oral Cancer) 09/2021
1	Cancer Pain 09/2021
1	Tongue Neoplasms (Tongue Neoplasm) 09/2021
1	Squamous Cell Carcinoma of Head and Neck 09/2021
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Diarrhea 01/2019
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2018
1	Autoimmune enteropathy 01/2016
1	Neurologic Manifestations (Neurological Manifestations) 01/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Celiac Disease (Celiac Sprue) 01/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2012
1	Fibrosis (Cirrhosis) 11/2012
1	Portal Hypertension 11/2012
1	Body Weight (Weight, Body) 04/2010

Drug/Important Bio-Agent (IBA)

4	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2018
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2023 - 12/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023 - 01/2021
2	Aprepitant (Emend)FDA Link 01/2022 - 12/2019
2	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 12/2014
2	cathepsin SIBA 09/2021 - 01/2018
2	Opioid Analgesics (Opioids)IBA 01/2020 - 12/2019
1	LipidsIBA 01/2023
1	AminesIBA 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	propionamideIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022
1	PolymersIBA 01/2022
1	Calcitonin Gene-Related PeptideIBA 01/2022
1	AnkyrinsIBA 01/2022
1	Calcitonin Receptors (Calcitonin Receptor)IBA 01/2022
1	ArrestinIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Dynamin IIIBA 01/2022
1	PAR-2 ReceptorIBA 01/2022
1	Receptor Activity-Modifying Protein 1IBA 01/2022
1	Neurokinin-1 Receptor AntagonistsIBA 01/2022
1	LY3000328IBA 09/2021
1	LigandsIBA 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Chemokine CX3CL1IBA 01/2020
1	Glutens (Glutelin)IBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	Substance PIBA 12/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Protamines (Protamine Sulfate)FDA Link 06/2018
1	ChannelrhodopsinsIBA 01/2018
1	Halorhodopsins (Halorhodopsin)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	OpsinsIBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	TrypsinIBA 01/2018
1	ClathrinIBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	AntibodiesIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	ChemokinesIBA 12/2014
1	Amibegron hydrochlorideIBA 11/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2012
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2010
1	EndocannabinoidsIBA 04/2010

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2018
1	Analgesia 01/2021
1	Spinal Injections 12/2019
1	Cannula 01/2018
1	Lasers (Laser) 01/2018